Deaths Resulting From Hypocalcemia After Administration of Edetate Disodium: 2003-2005

  title={Deaths Resulting From Hypocalcemia After Administration of Edetate Disodium: 2003-2005},
  author={Mary Jean Brown and Teresa Willis and Bennet I. Omalu and Richard D. Leiker},
  pages={e534 - e536}
From 2003 to 2005, deaths of 3 individuals as a result of cardiac arrest caused by hypocalcemia during chelation therapy were reported to the Centers for Disease Control and Prevention. Two were children, both of whom were treated with edetate disodium. At the time of this writing, the adult case was still under investigation. No previous cases of death resulting from hypocalcemia during chelation have been reported. From our experience and review of the literature, we suggest that health care… 

EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment

Administration of iv EDTA on weekly basis appears to be a sufficient and nontoxic protocol for treating patients with suspected overload and toxicity of xenobiotic metals especially Pb and Cd.

Magnesium Therapy in a Hypocalcemic African Grey Parrot (Psittacus erithacus)

It is believed that a primary dietary magnesium deficiency may have been present in this African grey parrot, similar to a syndrome in leghorn chicks, which is frequently characterized by progressive hypocalcemia that is unable to be corrected by calcium supplementation alone.

Expulsion by Ionic Complexation: Benchmark Therapy for Atherosclerosis A Review

It can be concluded that chelation therapy is emerging form of complementary or alternative medicine to surgery and can be used in safe manner.

Commentary on the Abuse of Metal Chelation Therapy in Patients with Autism Spectrum Disorders

  • J. Brent
  • Medicine
    Journal of Medical Toxicology
  • 2013
Bayesian principles tell us that further testing is likely to yield results within normal reference ranges, but under some circumstances, it is useful to do such testing in order to demonstrate that there is no need for chelation therapy.

Advances in the prevention and management of central-line–associated bloodstream infections: The role of chelator-based catheter locks

A detailed summary of the properties of chelators and in vitro and in vivo studies of chelator-containing lock solutions is presented.


The results of vitamin C supplementation during lead exposure have revealed significant improvements and therefore need further evaluation to see if it can ameliorate the toxicity of lead in conditions of unavoidable exposure.

The facts and fictions of chelation therapy

  • Medicine
  • 2019
Often dismissed as quackery, chelation therapy was the subject of a recently completed NIH study that showed the practice to be of moderate benefit to heart-attack survivors.

ACMT Recommends Against Use of Post-Chelator Challenge Urinary Metal Testing

The American College of Medical Toxicology reaffirms that post-chelator metal testing has not been scientifically validated, has no demonstrated benefit, and may be harmful when applied in the assessment and treatment of patients in whom there is concern for metal exposure or poisoning.

Dangers of "EDTA".

This letter is intended to raise medical practitioners’ awareness of the dangers of two similar sounding forms of edetate: edetate calcium disodium and edetate disodium. Edetate disodium has been



The treatment of acute lead encephalopathy in children.

Comparison of this group with a similar, but not simultaneously studied, group of patients treated with BAL indicates that while edathamil calcium disodium may have reduced the incidence of residual neurologic damage to a certain extent, it has not significantly reduced mortality from this disease.

Fatal pediatric lead poisoning--New Hamphshire, 2000.

The investigation of the first reported death of a child from lead poisoning since 1990 implicated leaded paint and dust in a home environment as the most likely source of the poisoning.

Preventing lead poisoning in young children: A statement by the Centers for Disease Control, October 1991

The statement reflects the vision expressed in the Department of Health and Human Services' Strategic Plan for the Elimination of Childhood Lead Poisoning, which calls for a concerted, coordinated societywide effort to eliminate this disease.

meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.

Preclinical and clinical evidence now indicate that meso-2,3-dimercaptosuccinic acid, an Orphan Drug, shows the most promise for being effective in this regard, and has an extracellular distribution that may be responsible for its low toxicity compared to other dithiols.

Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children.

The pattern and extent of changes in blood Pb and plasma Zn and Cu concentrations and of the urinary loss of these metals have been characterized in Pb-poisoned children receiving 5-day courses of Ca disodium EDTA.

Blood lead levels--United States, 1999-2002.

  • Medicine
    MMWR. Morbidity and mortality weekly report
  • 2005
The findings indicated that BLLs continued to decrease in all age groups and racial/ethnic populations, and approximately 310,000 children aged 1-5 years remained at risk for exposure to harmful lead levels.